Michael K. Sullivan , Jennifer S. Lees , Brenda M. Rosales , Rachel Cutting , Melanie L. Wyld , Mark Woodward , Angela C. Webster , Patrick B. Mark , Nicole De La Mata
{"title":"Sex and the Relationship Between Cardiometabolic Risk Factors and Estimated GFR Decline: A Population-Based Cohort Study","authors":"Michael K. Sullivan , Jennifer S. Lees , Brenda M. Rosales , Rachel Cutting , Melanie L. Wyld , Mark Woodward , Angela C. Webster , Patrick B. Mark , Nicole De La Mata","doi":"10.1053/j.ajkd.2024.05.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale & Objective</h3><div>Females have a higher prevalence of chronic kidney disease (CKD) than males but are less likely to be treated with kidney replacement therapy (KRT). We studied the interaction between sex and the association of cardiometabolic risk factors for the decline in kidney function over time.</div></div><div><h3>Study Design</h3><div>A population-based cohort study.</div></div><div><h3>Setting & Participants</h3><div>1,127,731 adults living in Wales, United Kingdom, within the Secure Anonymised Information Linkage Databank.</div></div><div><h3>Exposure</h3><div>Sex and risk factors including age, estimated glomerular filtration rate (eGFR), cardiometabolic conditions, smoking, and socioeconomic deprivation. These risk factors were defined using primary care records.</div></div><div><h3>Outcome</h3><div>The yearly declines in eGFR and the risk of incident kidney failure defined as long-term KRT and/or sustained eGFR<!--> <!--><<!--> <!-->15<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>.</div></div><div><h3>Analytical Approach</h3><div>Linear mixed effects models and Cox proportional hazards analysis.</div></div><div><h3>Results</h3><div>The average decline in eGFR at age<!--> <!-->≤73 years was equal in males and females. After age 73 years, eGFR decline was faster in males than females, particularly for males with heart failure (males<!--> <!-->−1.22<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> per year [95% CI, −1.25 to<!--> <!-->−1.20] vs females<!--> <!-->−0.87<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> per year [95% CI, −0.89 to<!--> <!-->−0.85]) and current smokers (males<!--> <!-->−1.58<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> per year [95% CI, −1.60 to<!--> <!-->−1.55] vs females<!--> <!-->−1.27<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> per year [95% CI, −1.29 to<!--> <!-->−1.25]). Socioeconomic deprivation was one of the most impactful risk factors on eGFR decline among females aged<!--> <!-->>73 years, whereas cardiometabolic risk factors were more important among males. Older females at baseline were less likely to develop incident kidney failure than older males (<em>P</em> for age<!--> <!--><<!--> <!-->0.001).</div></div><div><h3>Limitations</h3><div>Study of people who were almost exclusively White and who had blood laboratory test data. Reliance on creatinine-based eGFR. Albuminuria and body mass index data were incomplete.</div></div><div><h3>Conclusions</h3><div>The eGFR decline was faster in males than in females, especially in the setting of heart failure and smoking. Socioeconomic deprivation was an important risk factor associated with eGFR decline, particularly for females. further work is required to explore less well-recognized risk factors, but these findings may inform clinical management strategies of CKD overall and within sex-specific groups.</div></div><div><h3>Plain-Language Summary</h3><div>Kidney function is known to decline at a faster rate among males than females. This study incorporated blood laboratory test results from the routine care of 1.1 million adults living in the United Kingdom and found that the decline in kidney function associated with risk factors varied by sex. Before and at the age of 73 years, the decline in kidney function was similar between males and females. After age 73, cardiometabolic risk factors were associated with faster decline in kidney function among males than females, specifically heart failure and smoking. Socioeconomic deprivation was also associated with the decline in kidney function for both sexes, but it was a stronger risk factor among females. These findings may inform the management of kidney disease overall and within sex-specific groups.</div></div>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"84 6","pages":"Pages 731-741.e1"},"PeriodicalIF":9.4000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272638624008680","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale & Objective
Females have a higher prevalence of chronic kidney disease (CKD) than males but are less likely to be treated with kidney replacement therapy (KRT). We studied the interaction between sex and the association of cardiometabolic risk factors for the decline in kidney function over time.
Study Design
A population-based cohort study.
Setting & Participants
1,127,731 adults living in Wales, United Kingdom, within the Secure Anonymised Information Linkage Databank.
Exposure
Sex and risk factors including age, estimated glomerular filtration rate (eGFR), cardiometabolic conditions, smoking, and socioeconomic deprivation. These risk factors were defined using primary care records.
Outcome
The yearly declines in eGFR and the risk of incident kidney failure defined as long-term KRT and/or sustained eGFR < 15 mL/min/1.73 m2.
Analytical Approach
Linear mixed effects models and Cox proportional hazards analysis.
Results
The average decline in eGFR at age ≤73 years was equal in males and females. After age 73 years, eGFR decline was faster in males than females, particularly for males with heart failure (males −1.22 mL/min/1.73 m2 per year [95% CI, −1.25 to −1.20] vs females −0.87 mL/min/1.73 m2 per year [95% CI, −0.89 to −0.85]) and current smokers (males −1.58 mL/min/1.73 m2 per year [95% CI, −1.60 to −1.55] vs females −1.27 mL/min/1.73 m2 per year [95% CI, −1.29 to −1.25]). Socioeconomic deprivation was one of the most impactful risk factors on eGFR decline among females aged >73 years, whereas cardiometabolic risk factors were more important among males. Older females at baseline were less likely to develop incident kidney failure than older males (P for age < 0.001).
Limitations
Study of people who were almost exclusively White and who had blood laboratory test data. Reliance on creatinine-based eGFR. Albuminuria and body mass index data were incomplete.
Conclusions
The eGFR decline was faster in males than in females, especially in the setting of heart failure and smoking. Socioeconomic deprivation was an important risk factor associated with eGFR decline, particularly for females. further work is required to explore less well-recognized risk factors, but these findings may inform clinical management strategies of CKD overall and within sex-specific groups.
Plain-Language Summary
Kidney function is known to decline at a faster rate among males than females. This study incorporated blood laboratory test results from the routine care of 1.1 million adults living in the United Kingdom and found that the decline in kidney function associated with risk factors varied by sex. Before and at the age of 73 years, the decline in kidney function was similar between males and females. After age 73, cardiometabolic risk factors were associated with faster decline in kidney function among males than females, specifically heart failure and smoking. Socioeconomic deprivation was also associated with the decline in kidney function for both sexes, but it was a stronger risk factor among females. These findings may inform the management of kidney disease overall and within sex-specific groups.
期刊介绍:
The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.